Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tiziana Life Sciences PLC

1.89
-0.0665-3.39%
Volume:178.80K
Turnover:343.58K
Market Cap:221.25M
PE:-17.03
High:1.97
Open:1.95
Low:1.85
Close:1.96
52wk High:2.60
52wk Low:0.6295
Shares:116.85M
Float Shares:68.78M
Volume Ratio:0.64
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1112
EPS(LYR):-0.1112
ROE:-250.49%
ROA:-84.13%
PB:56.21
PE(LYR):-17.03

Loading ...

Tiziana Life Sciences Initiates Phase 2a Trial of Intranasal Foralumab for Multiple System Atrophy at Brigham and Women's Hospital

Reuters
·
Aug 14

Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System Atrophy

THOMSON REUTERS
·
Aug 14

FDA Approves Tiziana Life Sciences' Phase 2 IND for Innovative MSA Treatment with Intranasal Foralumab

Reuters
·
Aug 11

FDA Approves Tiziana Life Sciences Phase 2 Ind for Multiple System Atrophy

THOMSON REUTERS
·
Aug 11

Tiziana Life Sciences Unveils Promising Immunologic Findings from Nasal Foralumab Treatment in Alzheimer's Clinical Study

Reuters
·
Jul 21

Tiziana Life Sciences Adds Fifth Site for Phase 2 Foralumab Trial in Multiple Sclerosis

MT Newswires Live
·
Jun 13

Tiziana Life Sciences Announces Phase 2 Trial of Intranasal Foralumab for Alzheimer's Disease at Bio International Convention

Reuters
·
Jun 13

Tiziana Life Sciences Announces Promising Results of Nasal Foralumab in Treating Moderate Alzheimer's Disease, Published in Journal of Clinical Nuclear Medicine

Reuters
·
May 15

Tiziana Life Sciences Ltd. Files Amendment to 10-K Annual Report

Reuters
·
May 09

Why Tiziana Life Sciences Ltd (TLSA) is Surging in 2025

Insider Monkey
·
Apr 30

BRIEF-Tiziana Life Sciences Announces University of Massachusetts Starts Dosing Intranasal Foralumab in Phase 2 Multiple Sclerosis Trial

Reuters
·
Apr 23

BRIEF-Tiziana Life Sciences Announces Johns Hopkins University Commences Dosing Nasal Foralumab In Phase 2 Multiple Sclerosis Clinical Trial

Reuters
·
Apr 02

Tiziana Life Sciences files $250M mixed securities shelf

TIPRANKS
·
Mar 26

Tiziana Life Sciences announces dosing of new patients at Yale MS Center

TIPRANKS
·
Mar 26

Stocks to Watch Tuesday: Trump Media, Tesla, Samsung, GameStop -- WSJ

Dow Jones
·
Mar 25

BRIEF-Tiziana Life Sciences Ltd Files For Mixed Shelf Of Up To $250 Million - SEC Filing

Reuters
·
Mar 25

Tiziana Life Sciences to Present at the 37th Annual Roth Conference

GlobeNewswire
·
Mar 17

Tiziana Life Sciences Regains Compliance With Nasdaq Listing Rule

MT Newswires Live
·
Mar 14

Oramed Pharmaceuticals And 2 Other Penny Stocks With Promising Potential

Simply Wall St.
·
Mar 14

Tiziana Life Sciences Files New Drug Application for ALS Drug Candidate

MT Newswires Live
·
Mar 04